...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >NOVEL POLAROGRAPHIC METHODS FOR DETERMINATION OF PIOGLITAZONE HCL IN PURE FORM AND PHARMACEUTICAL FORMULATIONS
【24h】

NOVEL POLAROGRAPHIC METHODS FOR DETERMINATION OF PIOGLITAZONE HCL IN PURE FORM AND PHARMACEUTICAL FORMULATIONS

机译:极谱法测定纯形式和药物制剂中盐酸吡格列酮的含量

获取原文
   

获取外文期刊封面封底 >>

       

摘要

A sensitive methods are described for the determination of pioglitazone HCl(PGZ-HCl) as anti-diabetic drug in its pure form and pharmaceutical formulations. The proposed methods depends on the polarographic activity of PGZ-HCl in Britton-Robinson buffer over the pH range2-12 using direct current (DC) and differential pulse polarography (DPP), and it showed well-defined two cathodic peaks with high selectivity. Its electrochemical behavior at a dropping mercury electrode (DME) and stating mercury drop electrode (SMDE) has been investigated. Polarograms of the drug at DME & SMDE in B–R buffer at pH 6.0 exhibited two 2-electron irreversible cathodic peaks, the first peak (Ep1) is in the range of potential at -0.05V to -0.10V,while the second peak (Ep2) is in the potential ranges at -0.975V to -1.10V versus Ag/AgCl. The first and second peaks may be attributed to the reduction of oxy group (peak1) and C=N group (peak2), respectively. The diffusion current–concentration relationship was found to be rectilinear over the range1.6–224 μg.mL-1 and 1.6–28 μg.mL-1 for Ep1and over the ranges 1.6–256 μg.mL-1 and 1.6–32 μg.mL-1 for Ep2 using DME & SMDE, respectively, with limit of quantifying PGZ-HCl was 1.6 μg.mL-1, and relative standard deviation (RSD) ±4.0% & ±4.3% for Ep1 & Ep2 using DME and ±3.6% & ±3.8% for Ep1 & Ep2 using SMDE. The peaks were characterized as being irreversible, diffusion-controlled although adsorption phenomenon played a limited role in the electrode process. The proposed methods were novel, simple, accurate and successfully applied to the determination PGZ-HCl in pharmaceuticals and the average percentage recovery was in agreement with that obtained by the official USP method
机译:描述了一种灵敏的方法,用于测定吡格列酮HCl(PGZ-HCl)作为抗糖尿病药物的纯形式和药物制剂。所提出的方法取决于使用直流电(DC)和微分脉冲极谱法(DPP)在pH范围2-12内的Britton-Robinson缓冲液中PGZ-HCl的极谱活性,并且显示出定义明确的两个阴极峰,具有高选择性。已经研究了其在滴汞电极(DME)和固定汞滴电极(SMDE)上的电化学行为。在pH值为6.0的B–R缓冲液中DME和SMDE上的药物极谱图显示了两个2电子不可逆的阴极峰,第一个峰(Ep1)在-0.05V至-0.10V的电势范围内,而第二个峰(Ep2)在相对于Ag / AgCl的-0.975V至-1.10V的电位范围内。第一和第二峰可分别归因于氧基(peak1)和C = N基团(peak2)的还原。发现扩散电流与浓度的关系在Ep1的1.6–224μg.mL-1和1.6–28μg.mL-1范围内以及1.6–256μg.mL-1和1.6–32μg范围内呈直线关系使用DME和SMDE的Ep2的.mL-1分别为PGZ-HCl的定量限为1.6μg.mL-1,使用DME和EP2的Ep1和Ep2的相对标准偏差(RSD)为±4.0%和±4.3%使用SMDE的Ep1和Ep2的3.6%和±3.8%。尽管吸附现象在电极过程中的作用有限,但峰的特征是不可逆,受扩散控制。该方法新颖,简便,准确,已成功用于药物中PGZ-HCl的测定,平均回收率与美国药典中的平均回收率一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号